Bio-Techne (TECH) Cost of Revenue (2009 - 2026)

Bio-Techne has reported Cost of Revenue for 18 years, with the latest figure at $103.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 1.48% year-over-year to $103.1 million; the trailing twelve-month figure through Mar 2026 stood at $424.3 million (up 2.5% YoY), and the FY2025 full-year result was $429.4 million, up 10.28% from the prior year.
• Cost of Revenue for Q1 2026 stood at $103.1 million, down from $104.6 million in the prior quarter.
• The five-year high for Cost of Revenue was $118.2 million in Q2 2025, with the low at $87.9 million in Q2 2022.
• Average Cost of Revenue over 5 years is $98.2 million, with a median of $98.4 million recorded in 2025.
• Year-over-year, Cost of Revenue advanced 18.12% in 2022 and retreated 7.51% in 2025.
• Tracing TECH's Cost of Revenue over 5 years: stood at $88.2 million in 2022, then gained by 8.83% to $96.0 million in 2023, then increased by 7.43% to $103.1 million in 2024, then gained by 1.41% to $104.6 million in 2025, then dropped by 1.41% to $103.1 million in 2026.
• The last three Cost of Revenue figures came in at $103.1 million (Q1 2026), $104.6 million (Q4 2025), and $98.4 million (Q3 2025), per Business Quant data.

Peer Comparison